Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.9437
+0.0317 (3.48%)
At close: Jul 25, 2025, 4:00 PM
0.9300
-0.0137 (-1.45%)
After-hours: Jul 25, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Precision Oncology Therapies
7.00M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
7.00M